RESEARCH CENTRES

Division of Nephrology,
University of Leicester
Leicester General Hospital
Leicester, United Kingdom
Head
of the Unit |
John
Feehally MA DM FRCP John Feehally has led a research group in Leicester investigating the immunopathogenesis of IgA nephropathy since 1989. He is also co-editor of the successful postgraduate text, Comprehensive Clinical Nephrology. He is a Section Editor for Nephrology, Dialysis, Transplantation and Associate Editor of Nephron Clinical Practice. Contact Information Tel: +44 116 258 4132 Fax: +44 116 273 4674 Email: jf27@le.ac.uk |
Clinical
Staff |
John Feehally, Jonathan Barratt, and
Ursula Montogmery are clinicians as well as members of the IgA nephropathy
research group. |
Research
and Laboratory |
Jonathan Barratt PhD MRCP Elaine Foster BSc
Ursula Montgomery MB MRCP
|
| CONTACTS | |
| jf27@le.ac.uk | |
| Fax | +44 116 258 4764 |
| Full postal address | Division of Nephrology, Department of Medicine, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, United Kingdom |
IgAN
RESEARCH INTERESTS
CLINICAL RESEARCH
•
Recurrent IgA nephropathy in transplants
• Critical reviews of current treatment approaches to treatment of IgA
nephropathy
• New approaches to the treatment of IgA nephropathy
BASIC RESEARCH
RESEARCH PROGRAMMES AND PROJECTS LIST
•
IgA glycosylation
We were among the first to describe altered glycosylation of IgA1 in both
the serum and the kidney in IgA nephropathy, and we continue to investigate
its pathogenic significance.
•
Mesangial cell IgA receptors
We have described a novel Fc-specific IgA receptor in human mesangial cells,
and are continuing work to further characterise this receptor.
•
Cellular control of IgA synthesis
We have described exaggerated polymeric IgA responses in IgA nephropathy,
failure of affinity maturation in the IgA response and abnormal systemic responses
to mucosal antigens. We have also described abnormalities in the T cell repertoire
in the marrow and the mucosal immune system, and in T cell homing. Studies
of T cell control of IgA production continue.
•
Characterisation of IgA abnormalities in hepatic IgA nephropathy
The mechanisms underlying mesangial IgA deposition in chronic liver disease
have not yet been elucidated, nor have any putative structural abnormalities
of the IgA1 molecule such as are seen in primary IgA nephropathy. We are characterising
IgA1 in hepatic IgA nephropathy in collaboration with Dr. Shideh Pouria, King’s
College, London, UK
Fellows
program:
Specify if the Unit accepts from other Countries for:
Short(1-2 month) well focused trained programs either clinically or laboratory
oriented: Yes
Long (at least 1 year) research fellowships: Yes
Specify corresponding availability of grants: None
Specify if the Unit may provide help for accommodation: Yes
Prerequisites
for Fellowship
Language: English
Work/Research
experience:
• Research Scientists should be post-doctoral
• Clinician Scientists should have a minimum of 2
years research experience
Other
prerequisites: Written support from present institution
PUBLICATIONS LIST
IgAN Publications 2000-2003
| 1. | Feehally
J Treating IgA nephropathy – who, when and how? Nephron Clinical Practice 2003; 93:c47-c48 Pubmed Link |
| 2. | Smith
AC, Feehally J New insights into the pathogenesis of IgA nephropathy Springer Seminars in Immunopathology 2003 [in press] |
| 3. | Buck KS,
Foster EM, Watson D, Barratt J, Pawluczyk IZA, Knight JF, Feehally J,
Allen AC. Expression of T cell receptor variable region families by
bone marrow gd T cells in patients with IgA nephropathy. Clin Exp Immunol 2002;127(3):527-532. Pubmed Link |
| 4. | Feehally
J, Allen AC Abnormalities of IgA1 production in IgA nephropathy Nephrology 2002; 7: S100-S105 Pubmed Link |
| 5. | Tagboto
S, Feehally J, Carr SJ IgA nephropathy, anti-neutrophil cytoplasmic antibodies and crescentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome Am J Nephrol 2001; 21: 58-62 Pubmed Link |
| 6. | Allen
AC, Bailey EM, Brenchley PEC, Buck KS, Barratt J, Feehally J Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation Kidney Int 2001; 60:969-973 Pubmed Link |
| 7. | Feehally
J Predicting prognosis in IgA nephropathy Am J Kidney Dis 2001; 38: 881-3 Pubmed Link |
| 8. | Barratt
J, Allen AC, Feehally J Immunoglobulin A nephropathy In: Immunologic Renal Disease, Ed. Couser WG, Neilson EG 2001[in press] |
| 9. | Barratt
J, Greer M, Pawluczyk I, Allen AC, Bailey EM, Buck K, Feehally J Identification of a novel Fc alpha receptor expressed by human mesangial cells Kidney Int 2000; 57; 1936-1948 Pubmed Link |
| 10. | Zickerman
AM, Allen AC, Talwar V, Olczak SA, Brownlee A, Holland M, Furness PN,
Brunskill NJ, Feehally J IgA myeloma presenting as Henoch-Schönlein purpura with nephritis Am J Kidney Dis 2000; 36:E19 Pubmed Link |
| 11. | Feehally
J Immunoglobulin A nephropathy Horizons in Medicine 11, ed Pusey CD, Royal College of Physicians of London 2000: 285-300 Pubmed Link |
| 12. | Allen
AC, Feehally J IgA1 glycosylation and the pathogenesis of IgA nephropathy Am J Kidney Dis 2000; 35: 551-556 Pubmed Link |
| 13. | Floege
J, Feehally J IgA nephropathy: recent developments J Amer Soc Nephrol 2000; 11: 2395-2403 Pubmed Link |